The Cooper Companies, Inc. - Common Stock (COO)

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

11 large-cap stocks with worst performance in last week: SMMT, PDD, REGN, BAH, OKTA, DECK, CPRT, COO, TPL, HPQ, BURL. Mixed results, lowered forecasts.

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.

Cooper Companies beats Q2 estimates with $1 billion in sales and raises FY25 EPS forecast despite trimming revenue growth expectations.

Shares of medical device company CooperCompanies (NASDAQ:COO) fell 15% in the afternoon session after the company reported underwhelming first-quarter 2025 results (fiscal Q2), with sales exceeding expectations by a whisker while organic sales growth guidance for the full year was lowered. Management called out "softening in two of its growth markets, contact lenses and fertility." 

A strong May for U.S. equities is closing on a sour note, after President Donald Trump accused China of "totally" breaching a tariff agreement, raising new fears over trade disputes.

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Friday as we examine the latest happenings in today's session.

Jefferies upgraded Unity’s stock to ‘Buy’ from ‘Hold’ with a price target hike to $29 from $22.

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Friday. Stay informed about the latest market trends.

Pre-market stock analysis of S&P500 stocks on 2025-05-30: top gainers and losers in today's session.

The medical device maker raised its FY25 non-GAAP EPS guidance to $4.05–$4.11, topping Wall Street estimates, after reporting strong Q2 results.

Medical device company CooperCompanies (NASDAQ:COO) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 6.3% year on year to $1 billion. The company expects the full year’s revenue to be around $4.13 billion, close to analysts’ estimates. Its non-GAAP profit of $0.96 per share was 3.3% above analysts’ consensus estimates.

Medical device company CooperCompanies (NASDAQ:COO) will be reporting results tomorrow afternoon. Here’s what to look for.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 6.7%. This drop was discouraging since the S&P 500 held steady.

Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.

CooperCompanies’s stock price has taken a beating over the past six months, shedding 24.6% of its value and falling to $80.68 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.